{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T19:13:27Z","timestamp":1794338007484,"version":"4.9.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T00:00:00Z","timestamp":1620691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T00:00:00Z","timestamp":1620691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL140731"],"award-info":[{"award-number":["R01 HL140731"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL127028"],"award-info":[{"award-number":["R01 HL127028"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL107577"],"award-info":[{"award-number":["R01 HL107577"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Transthyretin amyloid cardiomyopathy, an often unrecognized cause of heart failure, is now treatable with a transthyretin stabilizer. It is therefore important to identify at-risk patients who can undergo targeted testing for earlier diagnosis and treatment, prior to the development of irreversible heart failure. Here we show that a random forest machine learning model can identify potential wild-type transthyretin amyloid cardiomyopathy using medical claims data. We derive a machine learning model in 1071 cases and 1071 non-amyloid heart failure controls and validate the model in three nationally representative cohorts (9412 cases, 9412 matched controls), and a large, single-center electronic health record-based cohort (261 cases, 39393 controls). We show that the machine learning model performs well in identifying patients with cardiac amyloidosis in the derivation cohort and all four validation cohorts, thereby providing a systematic framework to increase the suspicion of transthyretin cardiac amyloidosis in patients with heart failure.<\/jats:p>","DOI":"10.1038\/s41467-021-22876-9","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T10:04:54Z","timestamp":1620727494000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":113,"title":["A machine learning model for identifying patients at risk for wild-type transthyretin amyloid cardiomyopathy"],"prefix":"10.1038","volume":"12","author":[{"given":"Ahsan","family":"Huda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Casta\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anindita","family":"Niyogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faraz S.","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2791-9434","authenticated-orcid":false,"given":"Rahul C.","family":"Deo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5655-8201","authenticated-orcid":false,"given":"Sanjiv J.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,11]]},"reference":[{"key":"22876_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3949\/ccjm.84.s3.02","volume":"84","author":"JP Donnelly","year":"2017","unstructured":"Donnelly, J. P. & Hanna, M. Cardiac amyloidosis: an update on diagnosis and treatment. Cleve Clin. J. Med. 84, 12\u201326 (2017).","journal-title":"Cleve Clin. J. Med."},{"key":"22876_CR2","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","volume":"387","author":"AD Wechalekar","year":"2016","unstructured":"Wechalekar, A. D., Gillmore, J. D. & Hawkins, P. N. Systemic amyloidosis. Lancet 387, 2641\u20132654 (2016).","journal-title":"Lancet"},{"key":"22876_CR3","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","volume":"73","author":"FL Ruberg","year":"2019","unstructured":"Ruberg, F. L., Grogan, M., Hanna, M., Kelly, J. W. & Maurer, M. S. Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review. J. Am. Coll. Cardiol. 73, 2872\u20132891 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"22876_CR4","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1136\/heartjnl-2012-302353","volume":"98","author":"D Phelan","year":"2012","unstructured":"Phelan, D. et al. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart 98, 1442\u20131448 (2012).","journal-title":"Heart"},{"key":"22876_CR5","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.jacc.2017.05.053","volume":"70","author":"A Martinez-Naharro","year":"2017","unstructured":"Martinez-Naharro, A. et al. Magnetic resonance in transthyretin cardiac amyloidosis. J. Am. Coll. Cardiol. 70, 466\u2013477 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"22876_CR6","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","volume":"133","author":"JD Gillmore","year":"2016","unstructured":"Gillmore, J. D. et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation 133, 2404\u20132412 (2016).","journal-title":"Circulation"},{"key":"22876_CR7","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.cardfail.2019.08.001","volume":"25","author":"S Dorbala","year":"2019","unstructured":"Dorbala, S. et al. ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2-evidence base and standardized methods of imaging. J. Card. Fail 25, e1\u2013e39 (2019).","journal-title":"J. Card. Fail"},{"key":"22876_CR8","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1161\/CIRCULATIONAHA.111.078915","volume":"126","author":"FL Ruberg","year":"2012","unstructured":"Ruberg, F. L. & Berk, J. L. Transthyretin (TTR) cardiac amyloidosis. Circulation 126, 1286\u20131300 (2012).","journal-title":"Circulation"},{"key":"22876_CR9","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","volume":"36","author":"E Gonzalez-Lopez","year":"2015","unstructured":"Gonzalez-Lopez, E. et al. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur. Heart J. 36, 2585\u20132594 (2015).","journal-title":"Eur. Heart J."},{"key":"22876_CR10","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1093\/eurheartj\/ehx350","volume":"38","author":"A Castano","year":"2017","unstructured":"Castano, A. et al. Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. Eur. Heart J. 38, 2879\u20132887 (2017).","journal-title":"Eur. Heart J."},{"key":"22876_CR11","doi-asserted-by":"crossref","unstructured":"Aus dem Siepen, F. et al. Carpal tunnel syndrome and spinal canal stenosis: harbingers of transthyretin amyloid cardiomyopathy? Clin. Res. Cardiol. 108, 1324\u20131330 (2019).","DOI":"10.1007\/s00392-019-01467-1"},{"key":"22876_CR12","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1016\/j.jacc.2018.07.092","volume":"72","author":"BW Sperry","year":"2018","unstructured":"Sperry, B. W. et al. Tenosynovial and cardiac amyloidosis in patients undergoing carpal tunnel release. J. Am. Coll. Cardiol. 72, 2040\u20132050 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"22876_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3233\/JND-180348","volume":"6","author":"AS Carr","year":"2019","unstructured":"Carr, A. S. et al. Spinal stenosis in familial transthyretin amyloidosis. J. Neuromuscul. Dis. 6, 267\u2013270 (2019).","journal-title":"J. Neuromuscul. Dis."},{"key":"22876_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3109\/03009734.2014.895786","volume":"119","author":"P Westermark","year":"2014","unstructured":"Westermark, P., Westermark, G. T., Suhr, O. B. & Berg, S. Transthyretin-derived amyloidosis: probably a common cause of lumbar spinal stenosis. Ups. J. Med Sci. 119, 223\u2013228 (2014).","journal-title":"Ups. J. Med Sci."},{"key":"22876_CR15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/modpathol.2014.102","volume":"28","author":"A Yanagisawa","year":"2015","unstructured":"Yanagisawa, A. et al. Amyloid deposits derived from transthyretin in the ligamentum flavum as related to lumbar spinal canal stenosis. Mod. Pathol. 28, 201\u2013207 (2015).","journal-title":"Mod. Pathol."},{"key":"22876_CR16","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1001\/jama.2017.9236","volume":"318","author":"HI Geller","year":"2017","unstructured":"Geller, H. I., Singh, A., Alexander, K. M., Mirto, T. M. & Falk, R. H. Association between ruptured distal biceps tendon and wild-type transthyretin cardiac amyloidosis. JAMA 318, 962\u2013963 (2017).","journal-title":"JAMA"},{"key":"22876_CR17","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa, F. et al. Scikit-learn: machine learning in Python. J. Mach. Learn Res 12, 2825\u20132830 (2011).","journal-title":"J. Mach. Learn Res"},{"key":"22876_CR18","doi-asserted-by":"publisher","first-page":"e009985","DOI":"10.1161\/JAHA.118.009985","volume":"7","author":"MJ Feinstein","year":"2018","unstructured":"Feinstein, M. J. et al. Adjudicated heart failure in HIV-infected and uninfected men and women. J. Am. Heart Assoc. 7, e009985 (2018).","journal-title":"J. Am. Heart Assoc."},{"key":"22876_CR19","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1093\/bioinformatics\/btq126","volume":"26","author":"JC Denny","year":"2010","unstructured":"Denny, J. C. et al. PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations. Bioinformatics 26, 1205\u20131210 (2010).","journal-title":"Bioinformatics"},{"key":"22876_CR20","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1161\/CIRCULATIONAHA.119.045093","volume":"141","author":"DS Kazi","year":"2020","unstructured":"Kazi, D. S. et al. Cost-effectiveness of tafamidis therapy for transthyretin amyloid cardiomyopathy. Circulation 141, 1214\u20131224 (2020).","journal-title":"Circulation"},{"key":"22876_CR21","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.jchf.2019.04.010","volume":"7","author":"RM Witteles","year":"2019","unstructured":"Witteles, R. M. et al. Screening for transthyretin amyloid cardiomyopathy in everyday practice. JACC Heart Fail 7, 709\u2013716 (2019).","journal-title":"JACC Heart Fail"},{"key":"22876_CR22","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","volume":"379","author":"MS Maurer","year":"2018","unstructured":"Maurer, M. S. et al. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N. Engl. J. Med. 379, 1007\u20131016 (2018).","journal-title":"N. Engl. J. Med."},{"key":"22876_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13040-019-0193-0","volume":"12","author":"RJ Ellis","year":"2019","unstructured":"Ellis, R. J., Wang, Z., Genes, N. & Ma\u2019ayan, A. Predicting opioid dependence from electronic health records with machine learning. BioData Min. 12, 3 (2019).","journal-title":"BioData Min."},{"key":"22876_CR24","doi-asserted-by":"crossref","unstructured":"Deodhar, A. et al. Use of machine learning techniques in the development and refinement of a predictive model for early diagnosis of ankylosing spondylitis. Clin. Rheumatol. 32, 975\u2013982 (2020).","DOI":"10.1007\/s10067-019-04553-x"},{"key":"22876_CR25","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.yebeh.2018.10.013","volume":"89","author":"S An","year":"2018","unstructured":"An, S. et al. Predicting drug-resistant epilepsy - a machine learning approach based on administrative claims data. Epilepsy Behav. 89, 118\u2013125 (2018).","journal-title":"Epilepsy Behav."},{"key":"22876_CR26","first-page":"185","volume":"6","author":"O Uspenskaya-Cadoz","year":"2019","unstructured":"Uspenskaya-Cadoz, O. et al. Machine learning algorithm helps identify non-diagnosed prodromal Alzheimer\u2019s disease patients in the general population. J. Prev. Alzheimers Dis. 6, 185\u2013191 (2019).","journal-title":"J. Prev. Alzheimers Dis."},{"key":"22876_CR27","doi-asserted-by":"publisher","first-page":"e0203246","DOI":"10.1371\/journal.pone.0203246","volume":"14","author":"VS Nori","year":"2019","unstructured":"Nori, V. S., Hane, C. A., Martin, D. C., Kravetz, A. D. & Sanghavi, D. M. Identifying incident dementia by applying machine learning to a very large administrative claims dataset. PLoS ONE 14, e0203246 (2019).","journal-title":"PLoS ONE"},{"key":"22876_CR28","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1038\/s41591-019-0548-6","volume":"25","author":"J Wiens","year":"2019","unstructured":"Wiens, J. et al. Do no harm: a roadmap for responsible machine learning for health care. Nat. Med. 25, 1337\u20131340 (2019).","journal-title":"Nat. Med."},{"key":"22876_CR29","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1161\/CIRCULATIONAHA.115.001593","volume":"132","author":"RC Deo","year":"2015","unstructured":"Deo, R. C. Machine learning in medicine. Circulation 132, 1920\u20131930 (2015).","journal-title":"Circulation"},{"key":"22876_CR30","doi-asserted-by":"publisher","first-page":"e005289","DOI":"10.1161\/CIRCOUTCOMES.118.005289","volume":"12","author":"GH Tison","year":"2019","unstructured":"Tison, G. H., Zhang, J., Delling, F. N. & Deo, R. C. Automated and interpretable patient ECG profiles for disease detection, tracking, and discovery. Circ. Cardiovasc. Qual. Outcomes 12, e005289 (2019).","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"22876_CR31","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1161\/CIRCULATIONAHA.118.034338","volume":"138","author":"J Zhang","year":"2018","unstructured":"Zhang, J. et al. Fully automated echocardiogram interpretation in clinical practice. Circulation 138, 1623\u20131635 (2018).","journal-title":"Circulation"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22876-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22876-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22876-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T12:08:10Z","timestamp":1669982890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22876-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,11]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["22876"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-22876-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,11]]},"assertion":[{"value":"5 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.J.S. has received grants from Actelion, AstraZeneca, Corvia, Novartis, and Pfizer; and has received consulting fees from Actelion, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Cardiora, Eisai, Ionis, Ironwood, Merck, Novartis, Pfizer, Sanofi, and United Therapeutics. R.C.D. has received a grant from GE Healthcare and has received consulting fees from Novartis and Pfizer. A.C., M.B., A.H., A.N., M.S., and J.S. are full-time employees of Pfizer. All other authors report no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2725"}}